IS5267A - Skammtaform af sertralíni sem losna seint - Google Patents

Skammtaform af sertralíni sem losna seint

Info

Publication number: IS5267A
Authority: IS; Iceland
Prior art keywords: sertraline; late; dosage forms; dosage; forms
Prior art date: 1997-07-01

Application number

IS5267A

Other languages

English (en)

Inventor

John Curatolo William

Lewis Friedman Hylar

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1999-11-23

Publication date

1999-11-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5267(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-23 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

1999-11-23 Publication of IS5267A publication Critical patent/IS5267A/is

Links

239000002552 dosage form Substances 0.000 title 1
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title 1
229960002073 sertraline Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Addiction (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS5267A 1997-07-01 1999-11-23 Skammtaform af sertralíni sem losna seint IS5267A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5149997P	1997-07-01	1997-07-01
PCT/IB1998/000937 WO1999001122A1 (en)	1997-07-01	1998-06-16	Delayed-release dosage forms of sertraline

Publications (1)

Publication Number	Publication Date
IS5267A true IS5267A (is)	1999-11-23

Family

ID=21971681

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5267A IS5267A (is)	1997-07-01	1999-11-23	Skammtaform af sertralíni sem losna seint

Country Status (40)

Country	Link
EP (1)	EP1007024B1 (is)
JP (1)	JP3786715B2 (is)
KR (1)	KR100369698B1 (is)
CN (4)	CN1494899A (is)
AP (1)	AP1199A (is)
AR (1)	AR038394A2 (is)
AT (1)	ATE245415T1 (is)
AU (1)	AU727152B2 (is)
BG (1)	BG64742B1 (is)
BR (1)	BR9809895A (is)
CA (1)	CA2290969C (is)
DE (1)	DE69816624T2 (is)
DK (1)	DK1007024T3 (is)
DZ (1)	DZ2547A1 (is)
EA (1)	EA001906B1 (is)
ES (1)	ES2202858T3 (is)
GT (1)	GT199800091A (is)
HN (1)	HN1998000099A (is)
HR (1)	HRP980376B1 (is)
HU (1)	HUP0301787A3 (is)
ID (1)	ID23187A (is)
IL (2)	IL133081A (is)
IS (1)	IS5267A (is)
MA (1)	MA24585A1 (is)
NO (1)	NO996519L (is)
NZ (1)	NZ501249A (is)
OA (1)	OA11247A (is)
PA (1)	PA8454201A1 (is)
PE (1)	PE84399A1 (is)
PL (1)	PL337799A1 (is)
PT (1)	PT1007024E (is)
SI (1)	SI1007024T1 (is)
SK (1)	SK173299A3 (is)
TN (1)	TNSN98122A1 (is)
TR (1)	TR199903295T2 (is)
TW (1)	TW575437B (is)
UA (1)	UA63953C2 (is)
UY (1)	UY25068A1 (is)
WO (1)	WO1999001122A1 (is)
ZA (1)	ZA985710B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2348871C (en)	1998-11-02	2009-04-14	John G. Devane	Multiparticulate modified release composition
EP1178780B1 (en) *	1999-05-20	2007-07-18	ELAN CORPORATION, Plc	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
IE990406A1 (en)	1999-05-20	2000-12-27	Elan Corp Plc	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
PL211402B1 (pl)	1999-09-03	2012-05-31	Apbi Holdings	Zastosowanie dapoksetyny do leczenia lub zwalczania przedwczesnej ejakulacji
ES2168043B1 (es) *	1999-09-13	2003-04-01	Esteve Labor Dr	Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
EP1272165B1 (en) *	2000-02-10	2010-12-01	BPSI Holdings, Inc.	Acrylic enteric coating compositions
MXPA03001771A (es)	2000-08-30	2003-06-04	Pfizer Prod Inc	Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
US6482440B2 (en) *	2000-09-21	2002-11-19	Phase 2 Discovery, Inc.	Long acting antidepressant microparticles
US20040156900A1 (en) *	2001-04-10	2004-08-12	Shanghvi Dilip Shantilal	Time pulsed release composition
CA2457385A1 (en) *	2001-08-06	2003-02-20	Dr. Reddy's Laboratories Ltd.	Improved enteric formulation of fluoxetin
GB0607534D0 (en) *	2006-04-13	2006-05-24	Univ London Pharmacy	Colonic drug delivery formulation
EP2586429A1 (en) *	2011-10-26	2013-05-01	Freund Pharmatec Ltd.	Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) *	2017-12-27	2018-05-11	江苏联环药业股份有限公司	一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) *	2018-12-28	2019-03-08	乐普制药科技有限公司	一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) *	2021-11-19	2022-07-05	浙江维康药业股份有限公司	一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK150008C (da) *	1981-11-20	1987-05-25	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
EP0357364B1 (en) *	1988-08-30	1993-07-28	E.I. Du Pont De Nemours And Company	A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
IL91398A (en) *	1988-08-30	1994-05-30	Pfizer	Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US4983401A (en) *	1989-05-22	1991-01-08	Kinaform Technology, Inc.	Sustained release pharmaceutical preparations having pH controlled membrane coatings

1998
- 1998-06-16 PL PL98337799A patent/PL337799A1/xx unknown
- 1998-06-16 CA CA002290969A patent/CA2290969C/en not_active Expired - Fee Related
- 1998-06-16 SI SI9830494T patent/SI1007024T1/xx unknown
- 1998-06-16 AU AU75451/98A patent/AU727152B2/en not_active Ceased
- 1998-06-16 CN CNA200310118311XA patent/CN1494899A/zh active Pending
- 1998-06-16 BR BR9809895-0A patent/BR9809895A/pt not_active Application Discontinuation
- 1998-06-16 DE DE69816624T patent/DE69816624T2/de not_active Expired - Fee Related
- 1998-06-16 KR KR10-1999-7011529A patent/KR100369698B1/ko not_active Expired - Fee Related
- 1998-06-16 DK DK98923022T patent/DK1007024T3/da active
- 1998-06-16 ES ES98923022T patent/ES2202858T3/es not_active Expired - Lifetime
- 1998-06-16 WO PCT/IB1998/000937 patent/WO1999001122A1/en not_active Ceased
- 1998-06-16 PT PT98923022T patent/PT1007024E/pt unknown
- 1998-06-16 ID IDW991698A patent/ID23187A/id unknown
- 1998-06-16 AT AT98923022T patent/ATE245415T1/de not_active IP Right Cessation
- 1998-06-16 TR TR1999/03295T patent/TR199903295T2/xx unknown
- 1998-06-16 HU HU0301787A patent/HUP0301787A3/hu unknown
- 1998-06-16 EP EP98923022A patent/EP1007024B1/en not_active Expired - Lifetime
- 1998-06-16 CN CNA031489729A patent/CN1475208A/zh active Pending
- 1998-06-16 IL IL13308198A patent/IL133081A/xx not_active IP Right Cessation
- 1998-06-16 IL IL15230498A patent/IL152304A0/xx unknown
- 1998-06-16 NZ NZ501249A patent/NZ501249A/en unknown
- 1998-06-16 UA UA99116392A patent/UA63953C2/uk unknown
- 1998-06-16 CN CNA031489737A patent/CN1475209A/zh active Pending
- 1998-06-16 JP JP50677799A patent/JP3786715B2/ja not_active Expired - Fee Related
- 1998-06-16 EA EA199900965A patent/EA001906B1/ru unknown
- 1998-06-16 CN CNB988064294A patent/CN1151783C/zh not_active Expired - Fee Related
- 1998-06-16 SK SK1732-99A patent/SK173299A3/sk unknown
- 1998-06-25 AP APAP/P/1998/001278A patent/AP1199A/en active
- 1998-06-25 PA PA19988454201A patent/PA8454201A1/es unknown
- 1998-06-25 TW TW087110269A patent/TW575437B/zh active
- 1998-06-26 PE PE1998000577A patent/PE84399A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25068A patent/UY25068A1/es not_active IP Right Cessation
- 1998-06-29 GT GT199800091A patent/GT199800091A/es unknown
- 1998-06-30 MA MA25144A patent/MA24585A1/fr unknown
- 1998-06-30 ZA ZA9805710A patent/ZA985710B/xx unknown
- 1998-06-30 DZ DZ980157A patent/DZ2547A1/xx active
- 1998-06-30 HN HN1998000099A patent/HN1998000099A/es unknown
- 1998-06-30 TN TNTNSN98122A patent/TNSN98122A1/fr unknown
- 1998-07-01 HR HR980376A patent/HRP980376B1/xx not_active IP Right Cessation
1999
- 1999-11-23 BG BG103916A patent/BG64742B1/bg unknown
- 1999-11-23 IS IS5267A patent/IS5267A/is unknown
- 1999-12-23 OA OA9900307A patent/OA11247A/en unknown
- 1999-12-28 NO NO996519A patent/NO996519L/no not_active Application Discontinuation
2003
- 2003-02-05 AR ARP030100364A patent/AR038394A2/es active IP Right Grant

Also Published As

Publication number	Publication date
IL133081A0 (en)	2001-03-19
ATE245415T1 (de)	2003-08-15
BG103916A (en)	2000-07-31
DE69816624T2 (de)	2004-02-19
HK1027982A1 (en)	2001-02-02
OA11247A (en)	2002-11-19
AR038394A2 (es)	2005-01-12
EP1007024B1 (en)	2003-07-23
NO996519D0 (no)	1999-12-28
HN1998000099A (es)	1998-10-22
DZ2547A1 (fr)	2003-02-08
SK173299A3 (en)	2000-11-07
HUP0301787A3 (en)	2005-04-28
HRP980376B1 (en)	2002-12-31
DE69816624D1 (de)	2003-08-28
HRP980376A2 (en)	1999-04-30
ZA985710B (en)	2000-01-10
TW575437B (en)	2004-02-11
CA2290969C (en)	2004-02-17
TR199903295T2 (xx)	2000-08-21
CN1494899A (zh)	2004-05-12
IL152304A0 (en)	2003-05-29
AU7545198A (en)	1999-01-25
KR20010013522A (ko)	2001-02-26
PE84399A1 (es)	1999-09-11
CN1475208A (zh)	2004-02-18
BG64742B1 (bg)	2006-02-28
TNSN98122A1 (fr)	2005-03-15
NZ501249A (en)	2001-06-29
AP9801278A0 (en)	1998-06-30
NO996519L (no)	2000-02-29
UA63953C2 (uk)	2004-02-16
ES2202858T3 (es)	2004-04-01
AP1199A (en)	2003-08-28
EA199900965A1 (ru)	2000-08-28
PL337799A1 (en)	2000-09-11
JP2000513751A (ja)	2000-10-17
EP1007024A1 (en)	2000-06-14
AU727152B2 (en)	2000-12-07
BR9809895A (pt)	2000-08-01
PT1007024E (pt)	2003-11-28
CA2290969A1 (en)	1999-01-14
GT199800091A (es)	1999-12-21
MA24585A1 (fr)	1998-12-31
CN1151783C (zh)	2004-06-02
UY25068A1 (es)	2000-12-29
JP3786715B2 (ja)	2006-06-14
ID23187A (id)	2000-03-23
HUP0301787A2 (hu)	2003-11-28
IL133081A (en)	2005-09-25
CN1261273A (zh)	2000-07-26
DK1007024T3 (da)	2003-11-17
PA8454201A1 (es)	2000-09-29
WO1999001122A1 (en)	1999-01-14
EA001906B1 (ru)	2001-10-22
SI1007024T1 (en)	2003-12-31
KR100369698B1 (ko)	2003-01-30
CN1475209A (zh)	2004-02-18

Publication	Publication Date	Title
NO20003640D0 (no)	2000-07-14	Ny doseringsform
ATE262926T1 (de)	2004-04-15	Asorbierbare mikropartikel
AP9801281A0 (en)	1998-06-30	Sertraline salts and sustained-release dosage forms of sertraline
ATE321483T1 (de)	2006-04-15	Dose
DK0758244T4 (da)	2008-06-16	Doseringsformer af azithromycin med styret frigivelse
NO992692D0 (no)	1999-06-03	Nefadozon doseringsform
DE69812475D1 (de)	2003-04-30	Photoresistzusammensetzung
DE69908845D1 (de)	2003-07-24	Fotoresistzusammensetzung
NO996519L (no)	2000-02-29	Doseringsformer av sertralin med forsinket frigjøring
EE200000022A (et)	2000-10-16	Uus ravimvorm
DE69809633D1 (de)	2003-01-09	Photoresistzusammensetzung
DE69817687D1 (de)	2003-10-09	Positiv-Fotoresist-Zusammensetzung
DK0980241T3 (da)	2004-04-05	Gelatineindkapslede opløsningsdosisformer af sertralin
ID28032A (id)	2001-05-03	TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
IS4768A (is)	1998-06-10	Ný efnasambönd sem hafa verkjastillandi áhrif
NO996520L (no)	2000-02-29	Oppløste sertralinblandinger
DE59804724D1 (de)	2002-08-14	Fadenbremse
DE69802256D1 (de)	2001-12-06	Quecksilberlampe vom Kurzbogentyp
DE59807945D1 (de)	2003-05-22	Fadenbremse
DE69904662D1 (de)	2003-02-06	Fechtermaske
ATE230756T1 (de)	2003-01-15	B-ring estratriendiol-sulfate
ATA128198A (de)	2001-12-15	Dusche
ZA985707B (en)	2000-01-10	Sertraline salts and sustained-release dosage forms of sertraline.
FI4028U1 (fi)	1999-07-05	Valkosipulilevite
BR9701872A (pt)	1998-12-15	Suspensório para mouse